Study: NCT05294588

Intervention type: DRUG
Group type: OTHER
Intervention: Cefixime
Description: Mandatory rescue therapy consisting of cefixime 400 mg orally in a single dose: on patient request, at the onset of clinically apparent urethritis or on the 10th study day after inoculation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cefixime
Description: Mandatory rescue therapy consisting of cefixime 400 mg orally in a single dose: on patient request, at the onset of clinically apparent urethritis or on the 10th study day after inoculation.

Intervention type: DRUG
Group type: OTHER
Intervention: Ceftriaxone
Description: Mandatory rescue therapy consisting of ceftriaxone 250 mg intramuscularly in a single dose: on patient request, at the onset of clinically apparent urethritis or on the 10th study day after inoculation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Description: Mandatory rescue therapy consisting of ceftriaxone 250 mg intramuscularly in a single dose: on patient request, at the onset of clinically apparent urethritis or on the 10th study day after inoculation.

Intervention type: DRUG
Group type: OTHER
Intervention: Ciprofloxacin
Description: Mandatory antibiotic treatment failure therapy: Ciprofloxacin 500 mg orally in a single dose: if the subject has a positive N. gonorrhoeae test within 1 week post initial antibiotic treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Description: Mandatory antibiotic treatment failure therapy: Ciprofloxacin 500 mg orally in a single dose: if the subject has a positive N. gonorrhoeae test within 1 week post initial antibiotic treatment

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Neisseria gonorrhoeae strain FA1090
Description: 0.4 mL of a suspension containing 10\^5 - 10\^6 CFU of Neisseria gonorrhoeae, in phosphate-buffered saline, delivered to the anterior urethra through a No.8 pediatric French catheter.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Neisseria gonorrhoeae strain FA1090
Description: 0.4 mL of a suspension containing 10\^5 - 10\^6 CFU of Neisseria gonorrhoeae, in phosphate-buffered saline, delivered to the anterior urethra through a No.8 pediatric French catheter.

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Meningococcal Group B Vaccine
Description: All participants will receive 2 doses of the 4CMenB vaccine, 0.5 mL intramuscularly

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Meningococcal Group B Vaccine
Description: All participants will receive 2 doses of the 4CMenB vaccine, 0.5 mL intramuscularly

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Influenza Vaccine
Description: All participants will receive the quadrivalent influenza vaccine, 0.5 mL intramuscularly.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza Vaccine
Description: All participants will receive the quadrivalent influenza vaccine, 0.5 mL intramuscularly.

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Tetanus-diptheria Vaccine
Description: All participants will receive the Td vaccine, 0.5 mL intramuscularly.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tetanus-diptheria Vaccine
Description: All participants will receive the Td vaccine, 0.5 mL intramuscularly.